Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
This study involves approximately 200 patients designed to evaluate the efficacy and safety
of intranasal (IN) morphine 7.5 mg and 15 mg, intravenous morphine (IV) 7.5 mg, immediate
release oral (PO) morphine 60 mg or placebo in patients with acute postsurgical pain
following third molar extraction.